In a statement, the drug company said that it “has restarted the majority of its manufacturing lines” at the Rocky Mount, North Carolina facility, with full production expected to begin by the end of this year. Pfizer said it would take well into until next year to bring all the plant’s medicines back into full supply, which it defines as ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.